Literature DB >> 9850969

Projections of the amygdaloid body, ventral tegmental area, and substantia nigra to various segments of the nucleus accumbens in the dog brain.

A I Gorbachevskaya1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9850969     DOI： 10.1007/bf02462995

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN： 0097-0549


× No keyword cloud information.
  6 in total

Review 1.  [The structural organization and neurochemical mechanisms of the participation of the nucleus accumbens in the interaction of the limbic and motor systems and in the regulation of motor behavior].

Authors:  K B Shapovalova; A I Gorbachevskaia; N B Saul'skaia
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1992 Mar-Apr       Impact factor: 0.437

2.  Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain.

Authors:  A J McDonald
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

3.  [The organization of the afferent connections of the striatum--the structural basis for their functional specialization].

Authors:  A I Gorbachevskaia; O G Chivileva
Journal:  Fiziol Zh Im I M Sechenova       Date:  1994-01

4.  Tetramethyl benzidine for horseradish peroxidase neurohistochemistry: a non-carcinogenic blue reaction product with superior sensitivity for visualizing neural afferents and efferents.

Authors:  M M Mesulam
Journal:  J Histochem Cytochem       Date:  1978-02       Impact factor: 2.479

5.  Patterns of convergence and segregation in the medial nucleus accumbens of the rat: relationships of prefrontal cortical, midline thalamic, and basal amygdaloid afferents.

Authors:  C I Wright; H J Groenewegen
Journal:  J Comp Neurol       Date:  1995-10-23       Impact factor: 3.215

6.  Organization of thalamic projections to the ventral striatum in the primate.

Authors:  J M Giménez-Amaya; N R McFarland; S de las Heras; S N Haber
Journal:  J Comp Neurol       Date:  1995-03-27       Impact factor: 3.215
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.